{"filing":{"accession_number":"0001213900-26-090181","cik":"0001506251","ticker":"CTXR","company_name":"Citius Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-14","primary_document":"ea0302227-8k_citius.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390026090181/ea0302227-8k_citius.htm"},"events":[{"id":27985,"run_id":25564,"accession_number":"0001213900-26-090181","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 8-K discloses Citius Pharmaceuticals' fiscal third quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The press release reports Q3 revenues of $1.5 million and nine-month revenues of $7.1 million from LYMPHIR commercial sales, along with detailed financial statements showing gross profit, operating expenses, and net loss figures. This is a standard quarterly earnings disclosure with attached financial tables and operational highlights.","company_name":"Citius Pharmaceuticals, Inc.","ticker":"CTXR","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":29735,"accession_number":"0001213900-26-090181","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses Citius Pharmaceuticals' fiscal third quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The press release reports Q3 revenues of $1.5 million and nine-month revenues of $7.1 million from LYMPHIR commercial sales, along with detailed financial statements showing gross profit, operating expenses, and net loss figures. This is a standard quarterly earnings disclosure with attached financial tables and operational highlights.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:45:17.941774+00:00","company_name":"Citius Pharmaceuticals, Inc.","ticker":"CTXR","filing_date":"2026-08-14"}]}